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Abstract

Introduction

The discovery of an organic component in kidney
stones dates back to 1684. More than 150 years elapsed
before the incrustation of this organic component, which
is now called the matrix, was proposed as the mechanism of stone formation. The composition of the matrix
remained largely unknown until the development of electron microscopy and the advances in biochemistry combined in the 1950's to usher in the modern era of renal
stone matrix investigation. Composed mainly of selectively incorporated proteins generally characterized by
high glutamic and aspartic acid content and the frequent
occurrence of -y-carboxyglutamic acid, the matrix displays a variable and complex composition and shares a
few proteins in many stones. The embryonic stone may .
first appear in the renal tubules where it can acquire the
blood and cell membrane proteins recently found by
analysis of stone protein extracts. The combination of
supersaturation, an appropriate environment, the availability of calcium binding proteins which may be abnormal, and the incorporation of proteins extracted from
leukocytes and cell wall membranes may induce stone
formation.

The discovery that the "stone, " a long known source
of torment for humankind, has an organic component
dates back to 1684 when Von Hyde found that the calculus has an organic framework which we now call the
matrix [5]. The following century was remarkably silent
on this mundane topic until 1780 [26), when scientists
began to name and classify the organic components of
stones and eventually suggested incrustation of such as
the mechanism of stone formation [5].
Another century elapsed before Boyce, combining
the advances in electron microscopy and biochemistry,
brought the investigation of the organic component (matrix) into the modern era. Other research groups have
further expanded knowledge of the field and have progressively unravelled the composition of the matrix,
identifying many of its protein components. What follows is an account of this collective effort spanning
some 40 years and includes our unpublished work. It is
presented in the form of tables accompanied by a textual
commentary and key references.

Materials and Methods
Urinary and gallbladder stones obtained at surgery
or postmortem were stored at 4 °C until the proteins
were extracted. Sodium azide was used as a preservative. The stones were pulverized and the extraction was
performed in the model 1750 ISCO (Lincoln, NE) apparatus, originally devised to elute proteins from gels.
0.05 M sodium citrate buffer with a pH of 6.0 was
cooled by a refrigerated circulator with the current between 6.0-7.0 mA and the wattage at 3 W. Electrodialysis was continued until the readings at 280 nm were
negligible [1, 2). The extracts were pooled, concentrated and dialyzed against reverse osmosis distilled
water, passed through an AcA44 column (IBF Biotechnics, Villeneuve-la-Garenne, France) employing Tris
glycine buffer (0.023 M Tris, 0.008 M glycine adjusted
to a pH of 8.2 with standardized 1 N HCl). The eluents
were separated by their optical densities at 280 nm, concentrated after dialysis and lyophilized. Aliquots were
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only in the urine of stone formers and in some pathological conditions [19]. Matrix substance A, because of its
reported large contribution to stone matrix composition,
is likely to have been revisited by subsequent investigators. Unfortunately, more than one characterized protein has an isoelectric point around 4.5 and a molecular
weight between 30-40 kD [20]. The identity of matrix
substance A may therefore remain enigmatic.
Boyce [4] had also reported the absence ofhydroxyproline and hydroxylysine on amino acid analysis of matrix proteins and had suggested that the matrix of all urinary calculi is similar irrespective of crystalline composition. This assertion was reexamined by Spector et al.
[29] who analyzed calcium oxalate, uric acid and apatitestruvite stones and confirmed the important contribution
of aspartic and glutamic acids, but reported a distinct
protein composition of the matrix of these stones. The
following year, Lian et al. [17] reported that ;--carboxyglutamic acid (OLA) is present in the proteins of calcium containing stones, thus linking stone matrix proteins
with bone and blood clotting, calcium-binding proteins.
The resolution of kidney stone matrix proteins was
expanded by Sugimoto et al. [31] who used high performance liquid chromatography to separate EDTA extracts of stones, but did not characterize their proteins
beyond ranges of molecular weights and concluded that
the matrix protein composition is identical in all stones.
Fraij [9] reached the same conclusion after separating
SDS-solubilized matrix proteins by SDS gel electrophoresis, although the amounts of each major protein component, THP and albumin fluctuated widely. No protein
of molecular weight around 90 kD was reported by
Sugimoto et al. [31] while THP (94 kD) was one of the
major proteins identified by Fraij [9]. These discrepancies, likely the result of different methodologies (or possibly geography), continue to the present.
One well-characterized protein, 6-2M (or fragments
thereof), is the major constituent of matrix kidney stones
recovered from uremic patients [ 18] and also the precursor protein of the amyloid associated with long-term hemodialysis [10] . The formation of this stone matrix,
which displays the ultrastructure and the birefringence of
amyloid, is reportedly independent of dialysis, while the
amyloid which may be deposited elsewhere in the body,
particularly the joints, appears only after years of dialysis and is made of intact 6-2M [11]. Soluble proteins
have also been extracted from these stones but not investigated further. One of these soluble proteins is likely
amyloid P-component which has been found to accompany all forms of amyloid and reportedly shields it from
attack by proteolytic enzymes [35] . Such stones would
provide a fine opportunity to examine the relationship of
the amyloid fibril and the P-component and test the susceptibility of the matrix stone to proteolytic digestion

screened by isoelectric focusing (IEF) (FMC Bioproducts, Rockland, ME) using the Hoefer cooling platen
(Hoefer Scientific Instruments, San Fernando, CA) to
ensure suitability for two-dimensional (2-D) electrophoresis (method of O'Farrell) [2]. Briefly, IEF was
carried out in glass tubes (2.0 mm inner diameter) using
2.0% Resolytes pH 4.8 ampholines. Tropomyosin was
the internal standard: lower spot of molecular weight
(MW) 33 kD and isoelectric point (pl) 5.2.
After 10 minutes in buffer "O" {10% glycerol, 50
mM dithiothreitol, 2.3 % sodium dodecylsulfate (SDS)
and 0.0625 M tris; pH 6.8}, the tubes were sealed to the
top of stacking gels which were on top of 10 % acrylamide slab gels (0.075 mm thick), and SDS slab gel
electrophoresis was carried out for 4 hours at 12.5
mA/gel. The following protein standards were used:
myosin (220 kD); phosphorylase A (94 kD); catalase (60
kD) ; actin (43 kD); carbonic anhydrase (29 kD) ; and
lysozyme (14 kD). These standards appear as horizontal
lines when stained with Coomassie Brilliant Blue R-250.
The electrophoresed gels were transblotted onto PVDF
(polyvinylidene disulfide membranes, immobilin Millipore; Millipore Corp., Bedford, MA) overnight at 4°C
in 12.5 mM tris, pH 8.8 , 86 mM glycine and 10%
methanol at 200 mA, approximately 100 volts per gel.
Membranes were stained with 0. 1 % Coomassie blue in
50 % methanol, rinsed four times in ultrapure distilled
water and spots were marked, excised and sequenced on
an Applied Biosystems (Foster City, CA) 470A gas
phase sequencer/20PTH analyzer for NHrterminal
sequence, 20 cycles were run on each.
Results and Discussion
Not surprisingly, the first proteins extracted from
stones by Boyce and his associates included albumin and
Tamm-Horsfall protein (THP) [33], the two most abundant urinary proteins, as well as other proteins simply
classified by their electrophoretic mobility as a-globulins
and ;--globulins [4]. Boyce realized that incorporation
of proteins into stones is a selective process, an observation repeatedly confirmed [6]. Dialysis against ethylenediaminetetraacetic acid (EDTA) containing solutions had
been used to remove most of the crystalline component
of the stones, leaving a matrix which proved difficult to
solubilize. This prompted the use of immunological
methods in Boyce's early work.
The most immunologically abundant protein extracted from stones he called substance A, a protein characterized by a relatively high content of glutamic and
aspartic acids, a characteristic shared by other proteins
subsequently recovered from stones [3]. Moore and
Gowland [19], in a later study, were unable to confirm
the immunological oneness of substance A and, like
Boyce et al. [3], could not detect it in normal urine,
510
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vention of calcium oxalate stone formation [12).
Several proteins were added to this list using 2-D
electrophoresis of proteins recovered after the dissolution
of crystals formed in urine [22) or after formic acid extraction from stones [14]. Most of these proteins have
not been characterized beyond the determination of isoelectric point and molecular weight but two interesting
findings have emerged from this work: many low molecular weight proteins have been recovered and important
differences in electrophoretic patterns can be observed
between proteins obtained from crystals and proteins extracted from stones, suggesting caution in the interpretation of results obtained from a vivo experiments [14,
21, 22). The possibility of artifacts induced by the stone
protein extraction procedure or protein degradation during stone formation or tubular wall injury may explain
the large presence of low molecular weight proteins.
The discovery of a truncated a-1 antitrypsin in a 4
M guanidine extract of calcium oxalate stones matches
proteases discovered earlier in the same stones with the
most abundant protease inhibitor in human serum [36] .
Both enzyme(s) and inhibitor(s) may derive from leukocytes that were attracted to these foreign crystal formations and lost some of their baggage in the encounter
[8]. The connection of blood and stone has been more
precisely documented by the isolation from calcium oxalate crystals and stones of a protein which binds calcium
avidly , is a potent inhibitor of calcium oxalate crystallization in vitro and shares the N-terrninal amino acid
sequence of a prothrombin fragment recently identified
as Fl [30) . Its presence in crystals and stones enhances
its credentials as a player in stone formation. It also
raises, more pertinently, the importance of the posttranslational carboxylation of specific glutamic acid residues required for the binding of calcium and the biological activity of prothrombin, a vitamin K dependent function, again raising the question of the role of vitamin K
and its inhibition by warfarin in the formation of stones.
Blood and stones are again linked by a calprotectinlike protein extracted from calcium oxalate stones and
originally recruited from neutrophils and macrophages
losing weight from 36.5 kD to 30 kD in the process
[37]. The abundance of the protein in stones and its inhibitory potency on calcium oxalate crystal growth again
suggest a role in mineralization which remains to be
determined.
The complex protein composition of stone matrix
has been further expanded by the use of electrodialysis
to extract proteins from crushed urinary tract stones and
gallstones, followed by 2-D electrophoresis and selective
N-terminal amino acid microsequencing [l, 2). The results, not previously reported, are presented in Table 1
which includes many protein sequences not found in the
data bank as well as several proteins originating from

before and after removal of the P-component.
Remarkably, two serine proteases along with hemoglobin have been reported in formic acid extracted proteins of calcium-containing stones [25]. This suggests a
close encounter between crystals, red cells and neutrophils in the history of stone formation, with the cells
leaving their signatures in stone to record the event.
This injurious encounter may have occurred in the tubule, in which case, other proteins derived from cells
lining the tubules would be expected at the center of the
stone early in its formation. Could these proteolytic
enzymes remain active and participate in stone formation
and could their activity be demonstrated after extraction?
Nephrocalcin, the celebrated and shrouded protein,
may be an example of a deficient protein, as extracted
from stones and the urine of stone formers, possibly less
able to bind calcium because of reduced -y-carboxylation
of glutamic acid [23, 24, 34). The mechanism of the
GLA deficiency in nephrocalcin remains unknown but
has not been reported to be vitamin-K responsive nor
warfarin inducible, although osteocalcin reportedly is
[16). A recent N-terminal amino acid sequence identifies nephrocalcin with a light chain of inter-alphatrypsin
inhibitor [34), however, the absence of GLA and the
lack of homology with osteocalcin suggest that authentic
nephrocalcin remains to be sequenced.
Another stone-extracted protein, an important constituent of calcium oxalate monohydrate stones, uropontin, shares the same amino acid sequence as osteopontin
of bone and kidney, is rich in acidic amino acids but
lacks -y-carboxyglutamic acid [13) . It inhibits calcium
oxalate crystal growth in vitro, suggesting a shared in
vivo role in the complex process of mineralization. Uropontin may be an example of a protein exhibiting different behaviors in different pH environments or following
post-translational modifications such as phosphorylation
[28) . Elucidation of its precise function remains a
challenge.
Tamm-Horsfall protein, another major constituent of
kidney stone matrix proteins, isolated from urine in 1950
[33) and subsequently extracted from calcium oxalate
stones by Boyce [4], has been studied extensively but its
function remains elusive. It appears to be a chameleon
protein which may function as a promoter of crystallization when exposed to low pH solutions or in the presence of cations such as calcium, magnesium or sodium
[12). Self-aggregation ofTHP, which may be increased
in stone formers, may also increase viscous binding neutralizing the zeta potential of the electrostatic surface
charge. If conditions are reversed to high pH and low
concentrations of calcium and sodium, THP is transformed into an inhibitor of calcium oxalate crystal aggregation. The ability of citrate to preferentially bind
calcium may thus explain its beneficial role in the pre511
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Table 1. Stone sequences. Individual specimens are listed alphabetically with chemical composition, type of stone,
pl (isoelectric point), approximate molecular weight (in kD), and N-terminal sequence. All specimens were examined
by crystallography, polarized light and electron microscopy.
No

Type & Chemical
Composition

pl

App
MW

N-Tenninal Sequence

Status:j:

(kD)
A.

kidney stone

5.4

40

AVVGGGATLPEKLYGST

Unknown• A56049

Urate calcium oxalate

5.1

32

DPGSATDYRTAAVGSDT

Unknown - closest
homology
thrombospondin - PIR2
Accession C56046

4.9

30

XXQGAVEGELFYKKQYNDSV

Root adhesion protein

4.5

17

Blocked: Tryptic digest:
(Y)L VLQGVAPG(Q)LXLV

U nk.nown - PIR2
Accession B56046

5.6

42

(T)HSYFNDLAAETD

U nk.nown - PIR2
Accession H56046

5.7

44

TNTLRPNFAETAK

Unknown - PIR2
Accession G56046

4.7

21.5

AFELPPLPYAHDALQPHTSK

Closest homology E56049
Superoxide dismutase

B.

kidney stone
UrCaOx

5.4
5.1

40
32

AVVGGGATLPEKLYGST
N-tenninal
DPGSATDYRTYAAVGSDT

U nk.nown - PIR2
Accession A56049
Accession C56046

C.

kidney stone

5.4

40

AVVGGGATLPEKLYGST

Unknown - •

4.75

22

AEYVLPDLA YDYGALEX(H)I

Superoxide dismutase
C56049

4.5

17

Blocked NH terminal
•B56046

(Y)L VLQGV APG
(Q)LXLV

4.7

21.5

AFELPPLPYAHDALQPHTSK

Closest homology
Superoxide dismutase

4.8

23

AFELPPLPYAHDALQPHTSK

Superoxide dismutase

4.8

29

(Q)GQGAVEGELFYKKQYNDSV

Root adhesion protein

5.0

31

XXXXDLTIAKYDADLFAA

Unknown - PIR2
Accession E56046

5.9

40

AVVGGGATLPEKL YG(S)T

Unknown - PIR2
Accession A56049 - •

5.1

32

DPGSATDYRTYAAVGSDT

Unknown - PIR2
Accession C56046

47.7

GTVTTDGADIVVKTKG

Porin-P; 1 exception
residue is at V

D.

kidney stone
Urate calcium oxalate
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01 .

kidney stone
Urate calcium oxalate

5.1

32

DPGSATDYRTYAAVGSDT

Unknown - closest
C56046

E.

kidney stone
Urate calcium oxalate

6.0

41.5

NDQEQSKGFVED(S)X

Unknown - PIR2
Accession E56049

5.2

32.5

KDYELLNVSYD(P)T(R)EL Y (Q)

Closest homology
D56049
Sulfate binding protein

4.7

21.5

AFELPPLPY AHDALQPHIS

Superoxide dismutase

< 4.5

14

TQSLHYSSPRETLTDTIMAA

Unknown - Tyrosine
related - PIR2
Accession F56046

MLQSQLSQ(T)D-tryptic digest

Unknown - PIR2
Accession D56046

F.

Urate calcium oxalate
kidney stone

G.

Urate calcium oxalate

5.9

40

AVVGGGATLPEKL YG(S)T

Unknown - •

H.

Urate calcium oxalate

5.9

40

AVVGGGATLPEKL YG(S)T

Unknown - •

...

115 mg stone (AcA34)

5.4

40

AVVGGGATLPEKL YS(S)T

Unknown

kidney stone

27

HTDLSGKVFVFPRESVTDHV

Serum amyloid Pcomponent (SAP)

UrCaOx

27

HTDLSGKVFVFPRESVTDHV

Serum amyloid
p-component (SAP)

(R)TPEVTXVVVDV

lg gamma-x+C

RTPEVTXVVVDV

lg gamma chain

ASGNVKFfGEIVQSTXKV

Unknown

Similar to flagellin in
B-subtilis

J.

K.

L.

<

kidney stone
(UrCaOx)

4.8

kidney stone

5.65

43

MIINHNIAALNTYNRLSAN (N)

5.5

33.5

AEIYNKDGNKLDL YGKVDAR

4.65

21

MFSIPEQFSSATKTNLEAQF

Unknown - PIR2
Accession A56046

< 4.5

14

MLQSQLSQTPRLALADTVl(D)

Unknown - PIR2
Accession D56046

CaOx, monohydrate = 18%
MgNH 2P04 = 1 %; CaOx

5.4

33

AEIYNKDGNKLDL YGKIDG

Outer membrane
protein

dihydrate = 64% ; CaP04
(carbonate) = 6%; CaP04
(hydroxyl form) = 7% ;
Protein & bl = 15%

5.5

33.5

AEVYNKDGNKLDLYGKVTA

Outer membrane
protein similar to Porin
P-differs at 18-19

kidney stone

5.5

33.5

AEIYNKDGNKLDFYGKV
MLQSQLSQTPRLALADTV (l)D
SQLSQTPRLALADTV(I)

2: 1 lower = upper
minus 3 NH terminal
residues
D56046

14

TQSLHYSSPRETLTDTIMAA

Unknown - F56046

18

< 4.5

< 4.5
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M.

N.

< 4.5

Urate - CaOx
kidney stone

Calcium Phosphate 20%
(carbonate form)

Unknown (immediate
early protein) - PIR2
Accession 156046

MFSIPEQFSSATKTNLEAQF

Unknown - PIR2
Accession A56046

MLSLHTNAALSAQS

Unknown - PIR2
Accession 156046

MLSLHTNAAAL(S)AQS

Unknown - PIR2
Accession 156046

(D)VNGGGATLPQ(P)L YQ

Unknown

67

XAHKSEVAHRFKDLGE

Serum albumin

Calcium Phosphate 65%
(hydroxyl form)

5.6

43

MTPFMTEDFLLDTEFARRLY

Unknown - PIR 2
Accession A56045

Protein 15%
kidney stone

5.1

32

AEVYNKDGNKLDLYGKVDGI

Outer membrane
protein

5.2

32.5

AEIYNKDGNKVDL YGKAVGL

Outer membrane

t

All slightly different

Accession D56046

15

(Tryptic Digest) :
MLQSQLSQ(T)P-NH terminal
fragment from stone P#78

0.

CaOX = 80%; Uric acid =
10% (mono); NH 3 Acid
Urate = 3% ; Protein = 4%
kidney stone

P.

CaOX = 18%; CaOX =
64% ; (mono) (dihydrate)
MgNH 4P0 4 ·6H 20
Ca 10P0 4 = 6%

=

1 %;

< 4.5

XDVTGAGASFP

5.2

kidney stone

CaOx = 2% (mono); Uric
acid = 95 %; Protein = 3 %

Outer membrane
protein

33 .5

AEIYNKDGNKLDL YGKIDGL

53 .3

AVINTNNLLSL TTQINNLNK

< 4 .5

14

TQSLHYSSPRETL TDTIMAA

PIR2
Accession F56046

< 4.5

15

MLQSQLSQTPRLALADTVID

PIR2
Accession D56046

6.6

47.7

XXVT(T)DGADIVVKTK

Porin-P

DVNGGGATLPQPL YQ

Unknown same as
M#49
Accession A56045

Ca10(P04)6 = 7% ;
Protein = 4%

Q.

MLSLATNAALSAQS

5.4

40

AVVGGGATLPEKLYGST

Protein 3 - PIR2
A56049

4.8

29

(Q)GQGA VEGELFYKKQYNDSV

Root adhesion protein
B50H100
Same as 6H61#8H69
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R.

< 4 .5

15

MLQSQLSQTPRLALADTVID

CaOx (mono) = 83%;
CaP0 4 (carbonate form) =
3%

5.5

33.5

AE(M)YNKDGNKVDIYX
KVD MLXELEXAL

CaP0 4 (hydroxyl) = 12%

4.9

30

AEVYNKDGNKDVYGKVD
MLXELE(K)AL

Protein = 2%

4.7

22

MLTELEKALNSIIDVYHKYS

kidney stone

< 4.0

10.5

MLXELEKALNXIID
ML(T)ELEKALNXIIDVYHKY

S.

33 .5

Calcium binding

5.5

Ca 1cf0i3OH)6OH 2O =
38% (carbonate apatite)

4.9

30

(1)
AEVYNKDGNK(L)DVYGKVD
(2)
MLTELEKALNSIIXVY

Ratio of (1) to (2)-3 :2

NH 4H ·C5H 2O3N4 ·H 2O
= 7% ; Protein = 5%

4.75

22

ML TELEKALNSIIDVYHKYS

Calcium binding

< 4.0

10.5

ML TELEKALNSIIDVYHKYS

Bladder stone

AEMYNKDGNKVDIYXKVD

ML(T)ELEKALNS

6
5.4

(l)ML(T)ELEKALN(S)IIDV

Calcium binding

(2)XKMXQXERNIE

MRP-14

MLXELEKALN (S)IIDVY
40

AVVGGGATLPEKLYGST

Unknown•

43 .5

XXVT(T)DGADTVVKTK

Porin - P

CaOX(monohydrate) = 2%

< 4.5

15

MLQSQLSQTPRLALADTVID

Unknown D56046

Uric acid = 95%

4.8

29

(Q)GQGAVEGELFKKQYNDS

Root adhesion

DVNGGGATLPEKKYGST

Unknown

AVVGGGATLPEKLYGST

•

Protein = 3%
U.

Calcium binding

Bladder stone
MgNH4P04 ·6H2O
(struvite) = 50%

5

T.

(K5#46; #45 x-59;
e#78; P6 - PIR2
Accession D56046

Gallbladder stone

5.4

40

Cholesterol = 93 %;
Calcium bilirubinate = 4 %;
Mixed bile pigments = 3 %;
(Fraction II from AcA44
column)

t:

contained serum amyloid p-component (SAP) and was obtained from a patient with Alzheimer's disease.

t: Blocked.
:j:: The Accession numbers, asterisk and PIR2 indicate NH-terminal sequences of new protein fragments which we have
entered in the databank (Protein Information Resource, National Biomedical Research Foundation, Washington, DC).
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cell membranes and a few from bacterial cells. These
findings are consistent with the presence of bacterial
DNA in cholesterol gallstones [32] and the selectivity
and diversity of matrix proteins. They also provide
some evidence for the crystal injury of tubular epithelial
cells early in stone formation [15].
A different matrix protein profile recently obtained
by SDS gel electrophoresis of the pooled EDT A extracts
of five types of kidney stones features albumin as the
major component which is proposed as the protein that
binds most other proteins to form the matrix of all
stones [7]. This is a startling proposal which has the
following limitations: (1) The authors, in order to gather
enough material to study, pooled the stone extracts, thus
excluding the possibility of detecting individual variations in composition; (2) SDS gel electrophoresis may
have failed to detect differences in protein composition
which could have been revealed by 2-D electrophoresis.
This technique would probably have resolved the large
protein component migrating as 67 kD on SDS gel electrophoresis; (3) No mention is made of the residue after
extraction; (4) Proteins considered by other investigators
as major components of matrix are not reported.
We can summarize the present state of knowledge
of stone matrix proteins and "look into the seeds of time
and say which grain will grow and which will not" [27]
as follows: (1) The incorporation of proteins into the
matrix is selective: not all urinary proteins are present
nor are they democratically represented. (2) Considerable evidence sustains the diversity of protein composition
of stones of different types. (3) Stones, blood and tears
appear to have special affinity. (4) Some proteins are
shared by many stones but none is shared by all individual stones. (5) The presence of cell wall proteins in
stones is consistent with tubular wall injury as crystals
navigate the narrows of renal tubules or sink into the
walls [15]. (6) The protein volume expansion induced
by calcium binding may further impede the navigation of
incipient stones. (7) The role of vitamin K in y-carboxyglutamic acid formation and calcium binding, and
its inhibition by warfarin lead to interesting theoretical
and therapeutic considerations. (8) The expanded development of antisera may serve to visualize the distribution
of specific proteins on the cut surface of the stone and
to localize them in the renal tubule. (9) Local conditions, such as, urine pH, specific ion concentration, degree of hydration, and flow velocity may be important
factors in stone formation, affecting the solubility and
binding affinity of some proteins present in stones. (10)
Some stone proteins may be intrinsically different
through amino acid substitution, abnormal GLA formation, carboxylation or phosphorylation.
Thus, the confluence of supersaturation with one or
more favorable local conditions including eclectic protein

part1c1pation, cell wall injury and phagocytosis may
result in the formation of a stone.

Acknowledgements
We appreciate the assistance of the Dept. Veterans
Affairs Medical Center Office and Res. and Dev. Facility, especially Emily Buermann. We also thank Dr. D.
Haft of the National Biomedical Research Foundation.

References
[1] Binette JP, Binette MB (1991) The matrix of
urinary tract stones: Protein composition, antigenicity,
and ultrastructure. Scanning Microsc 5: 1029-1036.
[2] Binette JP, Binette MB (1994) Sequencing of
proteins extracted from stones. Scanning Microsc 8:
233-239 .
[3] Boyce WH (1968) Organic matrix of urinary
concretions. Am J Med 45: 673-683.
[4] Boyce WH, King JS, Fielden ML (1962) Total
non-dialyz.able solids in human urine XIII. Immunological detection of a component peculiar to renal calculous
matrix and to urine of calculous patients. J Clin Invest
41: 1180-1189.
[5] Butt AJ (1956) Historical survey of etiologic factors in renal lithiasis. In: Etiological Factors in Renal
Lithiasis. Butt AJ (ed.). Thomas, Springfield, IL. pp. 347 .

[6] Doyle IF, Ryall RL, Marshall VR (1991) Inclusion of proteins into calcium oxalate crystals precipitated
from human urine: A highly selective phenomenon. Clin
Chem 37: 1589-1594.
[7] Dussol B, Geider S, Lilova A, Leonetti F,
Dupuy P, Daudon M, Berland Y, Dagom JC, Verdier
JM (1995) Analysis of the soluble organic matrix of five
morphologically different kidney stones. Urol Res 23:
45-51.
[8] Elfrink JGR, Deiertauf M (1987) Enzyme release from polymorphonuclear leukocytes during interaction with calcium oxalate microcrystals. J Urol 138:
164-167.
[9] Fraij BM (1989) Separation and identification of
urinary proteins and stone matrix proteins by mini-slab
sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Clin Chem 35: 658-662.
[10] Gejyo F, Yamada T, Odani S, Nakagawa Y,
Arakawa M, Kunimoto T, Kataoka H, Suzuki M, Hirasawa Y, Shirahama T, Cohen AS, Schmid K (1985) A
new form of amyloid protein associated with chronic
hemodialysis was identified as 8-2 microglobulin.
Biochem Biophys Res Comm 129: 701-706.
[11] Gorevic PD, Munoz PC, Casey TT, DiRaimondo CR, Stone WJ, Prelli FC, Rodrigues MM, Powlik MD, Frangione B (1986) Polymeriz.ation of intact /3r
microglobulin in tissue causes amyloidosis in patients on
516

Urinary stone proteins
chronic hemodialysis. Proc Natl Acad Sci USA 83:
7908-7912.
[12] Hess B (1994) Tamm Horsfall glycoprotein and
calcium nephrolithiasis. Miner Electrolyte Metab 20:
393-398.
[13] Hoyer JR (1994) Uropontin in urinary calcium
stone formation. Miner Electrolyte Metab 20: 385-392.
[14] Jones WT, Resnick M (1990) The characterization of soluble matrix proteins in selected human renal
calculi using two-dimensional polyacrylamide gel electrophoresis. J Urol 144: 1010-1014.
[15] Khan SR (1995) Calcium oxalate crystal interaction with renal tubular epithelium: Mechanism of crystal adhesion and its impact on stone development. Urol
Res 23: 71-79.
[16] Knapen MHJ, Hamulyak K, Vermeer C (1989)
The effect of vitamin K supplementation on circulating
osteocalcin (bone GLA protein) and urinary calcium excretions. Ann Intern Med 111: 1001-1005.
[17] Lian JB, Prien EL, Glimcher ML, Gallop
(1977) The presence of protein bound -y-carboxylglutamic acid in calcium-containing renal calculi. J Clin
Invest 59: 1151-1157.
[18] Linke RP, Bommer J, Ritz E, Waldherr R,
Eulitz M (1986) Amyloid kidney stones of uremic patients consist of 112-microglobulin fragments. Biochem
Biophys Res Comm 136: 665-671.
[19] Moore S, Gowland GC (1975) The immunological integrity of matrix substance A and its possible detection and quantitation in urine. Br J Urol 47: 489-494.
[20] Morse RM, Resnick MI (1988) Urinary stone
matrix. J Urol 139: 602-606.
[21] Morse RM, Resnick MI (1988) A new approach to the study of urinary macromolecules as a participant in calcium oxalate crystallization. J Urol 139:
869-873.
[22] Morse RM, Resnick MI (1989) A study of the
incorporation of urinary macromolecules onto crystals of
different mineral compositions. J Urol 141: 641-644.
[23] Mustafi D, Nakagawa Y (1994) Characterization of calcium-binding sites in the kidney stone inhibitor
glycoprotein nephrocalcin with vanadyl ions. Electron
paramagnetic resonance and electron nuclear double resonance spectroscopy. Proc Natl Acad Sci USA 91:
11323-11327.
[24] Nakagawa Y, Ahmed MA, Hall SL, Deganello
S, Coe FL (1987) Isolation from human calcium oxalate
renal stones of nephrocalcin, a glycoprotein inhibitor of
calcium oxalate crystal growth. J Clio Invest 79: 17821787.
[25] Petersen TE, Thogersen I, Peterson SE (1989)
Identification of hemoglobin and two serine proteases in
acid extracts of calcium containing kidney stones. J Urol
142: 176-180.

[26] Scheele CW (1780) Chemical Observations and
Experiments on Air and Fire. J. Johnson and Co. ,
London.
[27] Shakespeare W (1624) MacBeth, Act I, Scene
III.
[28] Shiraga H, Min W, VanDusen WJ, Clayman
MD, Miner D, Terrell CH, Sherbotie JR, Foreman SU,
Przysiccki C, Nielson EG, Hoyer JR (1992) Inhibition
of calcium oxalate crystal growth in vitro by uropontin:
Another member of the aspartic acid rich protein superfamily. Proc Natl Acad Sci USA 89: 426-430.
[29] Spector AR, Gray A, Prien EL (1976) Kidney
stone matrix. Differences in acidic protein composition.
Invest Urol 13: 387-389.
[30] Stapleton AMF, Ryall RL (1995) Blood coagulation proteins and urolithiasis are linked: Crystal matrix
protein is the F 1 activation peptide of human prothrombin. Br J Urol 75: 712-719.
[31] Sugimoto T, Funae Y, Rubben H, Nishio S,
Hautman R, Lutzeyer W (1985) Resolution of proteins
in the kidney stone matrix using high-performance liquid
chromatography. Eur Urol 11: 334-340.
[32] Swidsinski A, Ludwig W, Pahlig H, Priem F
( 1995) Molecular genetic evidence of bacterial colonization of cholesterol gallstones. Gastroenterology 108:
860-864.
[33] Tamm I, Horsfall FL (1950) Characterization
and separation of an inhibitor of viral hemagglutination
present in urine. Proc Soc Exp Biol Med 74: 108-114.
[34] Tang Y, Grover PK, Moritz RL, Simpson RJ,
Ryall RL (1995) Is nephrocalcin related to the urinary
derivative (bikunin) of inter-a-trypsin inhibitor? Br J
Urol 75: 425-430.
[35] Tennent GA, Lovat LB, Pepys MB (1995) Serum amyloid P-component prevents proteolysis of the
amyloid fibrils of Alzheimer disease and systemic
amyloidosis. Proc Natl Acad Sci USA 92: 4299-4303.
[36] Umekawa T , Kohri K , Amasaki N, Yamate T,
Yoshida K , Tamamoto K , Susuki Y, Sinohara H, Kurita
T (1993) Sequencing of a urinary stone protein identical
to a-1 antitrypsin which lacks 22 amino acids. Biochem
Biophys Res Comm 193: 1049-1053.
[37] Umekawa T, Kurita T (1994) Calprotectin-like
protein is related to soluble organic matrix in calcium
oxalate urinary stone. Biochem Molec Biol Int 34: 309313.
Discussion with Reviewers
P.K. Grover: Though I agree that identification of matrix proteins is essential to define their role in stone
genesis, can the authors discuss or speculate as to why
these proteins are there?
Authors: Before the question concerning the role of
proteins (matrix) in stone formation can be answered,
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proteins through intimate cell contacts and are reminded
that stones, including struvite stones, are not pure.

proteins in stones should be extracted and characterized.
The method of extraction has been reported in previous publications and it results in extensive recovery, so
only a small portion of organic material remains that can
be measured as protein. These extracts are concentrated
by lyophilization or centricon centrifugation prior to isoelectric focusing and, if adequate, 2-D electrophoresis.
This method, besides its resolving power, allows microsequencing of N-terminal amino acids or digestion of the
polypeptide if the N-terminal is blocked. Proteins are
finely characterized including isoelectric point and approximate molecular weight in a process which opens
the possibilities of cloning and antisera production.
The future of this approach appears brighter with
the development of electrospray and laser desorption
mass spectrometry combined with computer generated
access to massive data and 2-D reproducible electrophoresis [39] . Such advances will be necessary to characterize the proteome; study of urinary and stone proteins
could be beneficiaries. However, this achievement will
not provide knowledge of single protein function in
urine, stones or cells but will expand the challenge to
explain the role of the organic phase in stone formation.
Difficulties include incomplete knowledge of the interactions between proteins and Ca [40, 44], the alterations in protein conformation and function brought about
by variable environments, and the organization of proteins into the matrix. Experiments have been designed
to dissect these problems and investigate them in simplified systems with interesting results but incomplete explanations. Increased complexity of experimental conditions , such as reported by Lieske et al. [42, 43] and by
Hammes et al. [41], whereby characterized chemical entities may be tested in cell cultures, should expand the
knowledge of the process of stone formation. The recent development of a genetic model of urolithiasis in
the rat may link the foreseen accomplishments in protein
isolation and characterization with the genetics of the rat
model, providing the means to study the proteins and
gene(s) involved and their role in stone formation [38].

K. Kohri: The authors identified many kinds of proteins as stone matrix substances. However, the effect of
these proteins on urinary stone formation is not known.
I think that these proteins are mostly derived from miscellaneous substances, such bacterial structure materials,
substances adhered to stone surface, and urinary excretion components. The authors have to describe the characters and the actions of the identified matrix proteins.
Also, we do not know what proteins are important
for stone formation, because the matrix proteins are different in the same stone mineral components.
Authors: We have determined the N-terminal sequences
of a number of stones, not just ones given in Table 1.
We have found MRP-14, calmodulin, serum amyloid Pcomponent, albumin, cal-protectin-like protein and several with homology to thrombospondin, a widely distributed protein. Upon submission to the data bank, the
fourteen new sequences had no homologies with known
proteins. Their accession numbers are listed in Table 1.
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B. Hess: How do the authors explain why proteins originating from cell membranes exclusively are present in
stones containing struvite or carbonate apatite, i.e. , in
stones formed by infection with urea-splitting bacteria?
Authors: The most important urea splitting organisms
are proteus, micrococcus urea, and aerobacter. Some
strains of pseudomonas, klebsiella, providencia, serratia
and staphylococcus are less frequent offenders. Certain
strains of escherichia can form traces of ammonia.
We found one sequence with partial homology with
Porin P in a stone which contained 1 % struvite. The
same sequence was in a stone with no struvite, only calcium phosphate (in carbonate and in hydroxyl form).
We think it likely that struvite stones acquire membrane
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